Vistagen Therapeutics, Inc. · NASDAQ:VTGN
Orbimed Advisors LLC's stake in Vistagen Therapeutics, Inc. fell below 5% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Orbimed Advisors LLC's stake in Vistagen Therapeutics, Inc. fell below 5%, 0 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ORBIMED ADVISORS LLC | 0% | 0 |
| ORBIMED CAPITAL LLC | 0% | 0 |
Source
Related
- Vistagen Therapeutics, Inc.
- Orbimed Advisors LLC
- Vistagen Therapeutics, Inc. shareholders
- Schedule 13G/A · Orbimed Advisors LLC · Feb 17, 2026
- Schedule 13G · Orbimed Advisors LLC · Nov 14, 2025
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP I, LLC · Aug 14, 2026
- Form 4 · Adler Reid G. · Jul 2, 2026
- Form 4 · Tressler Nick B. · Jul 2, 2026
- Form 4 · Singh Shawn · Jul 2, 2026